You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Part of the Oxford American Pocket Card series, the information for this small card was taken from the Oxford American Handbook of Oncology (Gary H. Lyman, ed.). It is designed to be an educational brochure on the pathophysiology, diagnosis and treatment of renal cancer. Figures and tables are included to enhance reader understanding.
In recent years, rapid progress in the understanding and treatment of hematologic cancer has occurred, with many new and exciting treatment therapies now available to clinicians. Cancer mortality rates have begun to fall as greater and greater progress has been made in both the diagnosis and treatment of malignant disease. There has been considerable progress in our understanding of the basic biology and molecular genetics of cancer as well as the development and availability of an increasing array of novel therapies to complement traditional modalities of surgery, radiation therapy and chemotherapy. Advances in cancer treatment have been accompanied by equally impressive progress in support...
Based on (work): Oxford handbook of oncology / edited by Jim Cassidy ... [et al.]. 3rd ed. 2010.
Lung cancer is a malignancy of epidemic proportions. In the United States, it is estimated that there will be more than 228,000 new cases of lunch cancer each year, with 40% of those presenting with Stage IV metastatic disease. Non-small cell lung cancers (NSCLC) make up approximately 70% of all lung cancers diagnosed. Ongoing advancements in medicine are raising the bar in oncology management, including NSCLCs. Data show that patients respond differently to the same drug. By identifying a sub-group of patients most likely to benefit from a specific drug therapy, patients can be confident that their treatment will provide optimal responses. A companion diagnostic enables personalized healthc...
This concise yet comprehensive volume provides oncologists and other healthcare professionals with essential, evidence-based guidance on the diagnosis and treatment of all major GI malignancies, including colorectal, pancreatic, liver and esophageal cancers.
Published in 2004: This new edition of Comprehensive Geriatric Oncology still offers an exhaustive review of the biology of cancer and aging, of the epidemiologic trends in the country and in the world, and of the clinical trials that concern cancer prevention and cancer treatment in the elderly.
None
Mikvah: A body of water used for ritual immersion in Judaism. An attack at a local mikvah rocks a small Jewish community, leaving a holocaust survivor dead and the wife of a popular rabbi clinging to life. Peter Stem, a reclusive church employee has been arrested at the scene and taken into custody in what appears to be an anti-Semitic attack against two helpless women. Advocating for Peter is his employer, Father Herbert McCormick, a blind priest, who refuses to believe Peter capable of this or any crime. Using his personal relationship with John Collins, the arresting officer whom he has counseled in the past, Father McCormick steers the investigation in a new direction, one that requires the help of a renowned psychiatrist-a man who has a growing interest in both Peter's case and the Rabbi's mother-and will ultimately reveal a bigger secret than any of them could have imagined.
Progress in the treatment of cancer over the past two decades has been rapid with many new and novel therapeutic modalities arriving at an unprecedented pace. Overall cancer mortality rates have actually begun to fall in parallel with progress in the diagnosis and treatment of malignant disease. Despite our advances in the understanding of the biology and molecular genetics of cancer, as well as the availability of an increasing array of effective therapies, cancer treatment today and for the foreseeable future will include the traditional modalities of surgery, radiation therapy and chemotherapy. Myelosuppressive agents with their potential hematopoietic toxicities remain the mainstay of sy...
In recent years, rapid progress in the understanding and treatment of cancer has occurred, with many new and exciting treatment therapies now available to clinicians. Cancer mortality rates have begun to fall as greater and greater progress has been made in both the diagnosis and treatment of malignant diseases. Moreover, there has been considerable progress in our understanding of the basic biology and molecular genetics of cancer as well as the development and availability of an increasing array of novel therapies to complement the traditional modalities of surgery, radiation therapy and chemotherapy. These modalities greatly improved the ability of oncologists to reduce the adverse impact...